Stay updated on Pembrolizumab in HER2+ Gastric Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in HER2+ Gastric Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-21T14:51:23.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The site footer revision marker changed from v3.7.1 to v3.7.2; the study page remains an access-denied error.
    Difference
    0.2%
    Check dated 2026-10-14T15:21:09.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer’s displayed revision changed from v3.7.0 to v3.7.1, while the page continues to show a 403 error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-07T14:52:51.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a simple header and a Home link. This replaces the previous study record content for the NCT03615326 entry.
    Difference
    20%
    Check dated 2026-09-23T20:12:58.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.6 to v3.7.0, indicating a new version of the study record; this reflects a metadata/documentation update rather than a substantive modification to the trial details.
    Difference
    0.0%
    Check dated 2026-09-16T22:02:10.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now reflects software revision v3.6.6, replacing the previous v3.6.5. This indicates a minor platform update rather than a substantive change to trial information.
    Difference
    0.0%
    Check dated 2026-09-02T19:29:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in HER2+ Gastric Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.